dc.contributor.author
Rosa Rosa, Juan Manuel
dc.contributor.author
Leskela, Susanna
dc.contributor.author
Cristóbal Lana, Eva
dc.contributor.author
Santón, Almudena
dc.contributor.author
López García, Ma. Ángeles
dc.contributor.author
Muñoz, Gloria
dc.contributor.author
Pérez Mies, Belén
dc.contributor.author
Biscuola, Michele
dc.contributor.author
Prat, Jaime
dc.contributor.author
Oliva, Esther
dc.contributor.author
Soslow, Robert A.
dc.contributor.author
Matias-Guiu, Xavier, 1958-
dc.contributor.author
Palacios, José
dc.date.issued
2018-10-16T13:24:26Z
dc.date.issued
2018-10-16T13:24:26Z
dc.date.issued
2016-11-01
dc.date.issued
2018-07-24T12:16:02Z
dc.identifier
https://hdl.handle.net/2445/125366
dc.description.abstract
Undifferentiated and dedifferentiated endometrial carcinomas are rare and highly aggressive subtypes of uterine cancer, not well characterized at a molecular level. To investigate whether dedifferentiated carcinomas carry molecular genetic alterations similar to those of pure undifferentiated carcinomas, and to gain insight into the pathogenesis of these tumors, we selected a cohort of 18 undifferentiated endometrial carcinomas, 8 of them with a well-differentiated endometrioid carcinoma component (dedifferentiated endometrioid carcinomas), and studied them by immunohistochemistry and massive parallel and Sanger sequencing. Whole-exome sequencing of the endometrioid and undifferentiated components, as well as normal myometrium, was also carried out in one case. According to The Cancer Genome Atlas classification, we distributed 95% of the undifferentiated carcinomas in this series as follows: (a) hypermutated tumors with loss of any mismatch repair protein expression and microsatellite instability (eight cases, 45%); (b) ultramutated carcinomas carrying mutations in the exonuclease domain of POLE (two cases, 11%); (c) high copy number alterations (copy-number high) tumors group exhibiting only TP53 mutations and high number of alterations detected by FISH (two cases, 11%); and (d) low copy number alterations (copy-number low) tumors with molecular alterations typical of endometrioid endometrial carcinomas (five cases, 28%). Two of the latter cases, however, also had TP53 mutations and higher number of alterations detected by FISH and could have progressed to a copy-number high phenotype. Most dedifferentiated carcinomas belonged to the hypermutated group, whereas pure undifferentiated carcinomas shared molecular genetic alterations with copy-number low or copy-number high tumors. These results indicate that undifferentiated and dedifferentiated endometrial carcinomas are molecularly heterogeneous tumors, which may have prognostic value.
dc.format
application/pdf
dc.publisher
Nature Publishing
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1038/modpathol.2016.132
dc.relation
Modern Pathology, 2016, vol. 29, num. 11, p. 1390-1398
dc.relation
https://doi.org/b10.1038/modpathol.2016.132
dc.rights
(c) Springer Nature, 2016
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject
Càncer d'endometri
dc.subject
Genètica molecular
dc.subject
Endometrial cancer
dc.subject
Molecular genetics
dc.title
Molecular genetic heterogeneity in undifferentiated endometrial carcinomas
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion